Multi-omics molecular treatment targets for Prostate Cancer

Project Information

PCaProTreat

Grant agreement ID: 800048

DOI 10.3030/800048

Project closed

EC signature date 15 March 2018

Start date 1 April 2018

End date 31 March 2020

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost € 171 460,80

EU contribution € 171 460,80

Coordinated by

MOSAIQUES DIAGNOSTICS GMBH
Germany

Publications

Peer reviewed articles (3)

Promise and Implementation of Proteomic Prostate Cancer Biomarkers

Author(s): Agnieszka Latosinska, Maria Frantzi, Axel S. Merseburger, Harald Mischak
Published in: Diagnostics, Issue 8/3, 2018, Page(s) 57, ISSN 2075-4418
Publisher: MDPI AG
DOI: 10.3390/diagnostics8030057

Clinical Proteomics: Closing the Gap from Discovery to Implementation

Author(s): Maria Frantzi, Agnieszka Latosinska, Georgia Kontostathi, Harald Mischak
Published in: PROTEOMICS, Issue 18/14, 2018, Page(s) 1700463, ISSN 1615-9853
Publisher: John Wiley & Sons Ltd.
DOI: 10.1002/pmic.201700463

Clinical Proteomics on the Path Toward Implementation: First Promises Delivered

Author(s): Maria Frantzi, Harald Mischak, Agnieszka Latosinska
Published in: PROTEOMICS – Clinical Applications, Issue 13/2, 2019, Page(s) 1800094, ISSN 1862-8346
Publisher: Wiley - VCH Verlag GmbH & CO. KGaA
DOI: 10.1002/prca.201800094